Riskpilot← Back to searchSign inGet full accessOSGARDEN BIOVARME AS
ASActiveOrg 998621836Almannveien 81, 2550 Os I ØsterdalenProduction of electricity from renewable sources · NACE 3512Est. 20120 employees
Revenue 2024
NOK 74K
-31% vs 2023
EBITDA margin
92.6%
+150% vs 2023
Equity ratio
62.9%
Financial strength
Net profit 2024
NOK 25K
+470% vs 2023
| Revenue | NOK 74K | -31% |
| EBITDA | NOK 68K | +150% |
| Net profit | NOK 25K | +470% |
| Total assets | NOK 508K | -9% |
| Equity | NOK 320K | +8% |
| Employees | 0 | — |
Legal name
OSGARDEN BIOVARME AS
Org number
998621836
Legal form
Aksjeselskap
NACE code
3512 · Production of electricity from renewable sources
Founded
1. august 2012
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i felleskap.
Company purpose
Produksjon og salg av fjernvarme produsert på biobrensel samt annen type virksomhet som naturlig hører sammen med dette, herunder deltakelse i andre foretak.
Address
Almannveien 81, 2550 Os I Østerdalen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 59 | 59 | 65 | 106 | 74 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 34 | 33 | 32 | 27 | 68 |
| Depreciation & amort. | −25 | −25 | −25 | −25 | −25 |
| EBIT | 9 | 8 | 7 | 3 | 44 |
| Net financials | −10 | −6 | −6 | −11 | −12 |
| Profit before tax | −1 | 2 | 1 | −9 | 32 |
| Tax | −0 | 0 | 0 | −2 | 7 |
| Net profit | −0 | 2 | 1 | −7 | 25 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 619 | 590 | 558 | 559 | 508 |
| Equity | 299 | 301 | 302 | 295 | 320 |
| Long-term debt | 306 | 272 | 238 | 204 | 170 |
| Short-term debt | 14 | 17 | 19 | 60 | 19 |
| Total debt | 320 | 289 | 257 | 264 | 189 |
EBITDA margin
92.6%
This company
15.8%
Market median
+486% vs market
20202024
Equity ratio
62.9%
This company
38.2%
Market median
+65% vs market
20202024
Return on equity
7.8%
This company
18.4%
Market median
-58% vs market
20202024
Net profit margin
33.6%
This company
8.1%
Market median
+315% vs market
20202024
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
20202024
Debt / equity
0.59×
This company
0.62×
Market median
+5% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LI Chief Executive Officer | Chief Executive Officer | 2012 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2012 | |
| Board of Directors | 2012 | |
| Board of Directors | 2012 | |
| Chairman | 2012 | |
LO | Chairman | 2026 |
| Deputy Chairman | 2012 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OSGARDEN BIOVARME AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Inge Ytterhaug | Chief Executive Officer | 0 companies |
| Grete Irene Kroken | Board of Directors | 0 companies |
| Beate Ramlo | Board of Directors | 0 companies |
| Britt Elin Ramlo Horten | Board of Directors | 0 companies |
| Per Arnfinn Kroken | Chairman | 0 companies |
| Lars Os | Chairman | 0 companies |
| Kjell Horten | Deputy Chairman | 0 companies |